You're 47. You've noticed the gut. You've been reading about everyone's favorite approach. Joe Rogan is on carnivore. The biohacking podcast guy you like is running prolonged fasts. Your doctor mentioned Wegovy. Your brother-in-law tried keto and hates it. You're trying to figure out which path is actually worth committing to.
Let's do the honest head-to-head. GLP-1s, carnivore (all-meat or nearly so), and intermittent/prolonged fasting — three distinct approaches with real advocates and real success stories. But also three approaches with meaningfully different effect sizes, sustainability profiles, safety considerations, and fit for different men.
Here's what the evidence actually says and how to pick the right lane.
The three approaches in honest terms
GLP-1 Medications
Weekly injection (or daily oral) of semaglutide or tirzepatide. Reduces appetite and food noise through gut-brain hormone pathways. Originally developed for Type 2 diabetes; FDA-approved for obesity since 2021.
Carnivore Diet
All animal foods — meat, eggs, some dairy — with zero or minimal plants. Marketed by Jordan Peterson, Shawn Baker, and others. Produces rapid weight loss primarily through dramatic caloric restriction (boredom with food) and high protein satiety.
Intermittent/Prolonged Fasting
Time-restricted eating (16:8, 18:6, OMAD) or longer periodic fasts (24–72+ hours). Popularized by Peter Attia, Valter Longo, biohacking community. Produces weight loss through overall caloric restriction and metabolic adaptation.
Effect size: the uncomfortable truth
When you look at what each approach actually produces over 12 months for the average man starting at ~25% body fat:
| Approach | Avg weight loss (12 mo) | Muscle preservation | Adherence at 12 mo |
|---|---|---|---|
| GLP-1 (tirzepatide) | 21% (SURMOUNT-1)1 | Good with training + protein | ~85% |
| GLP-1 (semaglutide) | 15% (STEP-1)2 | Good with training + protein | ~85% |
| Strict carnivore | 10–20% (observational) | Good (high protein) | ~20–30% |
| 16:8 intermittent fasting | 3–8% (RCT meta-analyses)3 | Good if timed well | ~50–60% |
| Alternate-day fasting | 6–10% | Variable | ~30–40% |
For adherence, the gap is large. GLP-1 users stick with their protocol at ~85% one-year rates because the drug carries most of the behavioral load. Carnivore adherents drop to 20–30% by year one because eliminating every plant food forever is socially and practically difficult. Fasting adherents do better — around 50–60% — because it's more flexible and less socially constraining.
What each approach does well
What GLP-1s do well for men over 40
- Produce the largest weight loss of the three with the least willpower requirement.
- Improve cardiovascular outcomes (SELECT trial: 20% MACE reduction).4
- Address obesity-driven testosterone suppression (53% → 77% normalization over 18 months).5
- Fit around any dietary pattern — you can still eat your wife's cooking, go to restaurants, attend social events.
- Deliver results regardless of whether your willpower is reliable that week.
- Are evidence-based with 10,000-patient RCTs.
What carnivore does well
- Eliminates ambiguous food decisions — very simple rule set.
- Produces rapid initial weight loss (partly water loss, partly appetite suppression from boredom).
- Some men report dramatic improvements in specific conditions — autoimmune symptoms, ulcerative colitis, rheumatoid arthritis.
- Can normalize some inflammatory markers in sensitive individuals.
- Encourages protein-forward eating, which supports lean mass.
- Works for men who do well with binary rules.
What fasting does well
- Free — saves money rather than costing money.
- Extremely simple framework (no calorie counting).
- Flexible about what you eat during feeding windows.
- Some evidence for improved insulin sensitivity.
- Potential autophagy benefits (still debated at the scale experienced in IF).
- Works alongside most dietary patterns.
- Zero supply chain risk.
Where each approach fails
Where GLP-1s fail
- Require ongoing medication (usually for life, treating obesity as chronic disease).
- GI side effects in ~30% of men during titration.
- Cost, even at 2026 TrumpRx pricing ($149–$350/month).
- Regain rate is high if discontinued without structured maintenance (STEP 1 extension: ~66% regain within a year).6
- Not appropriate for men with personal or family history of medullary thyroid cancer, MEN2, or pancreatitis.
- Requires habit infrastructure (training, protein) to produce good body composition rather than just scale weight loss.
Where carnivore fails
- Sustainability is low for most men — by year 2, most have drifted back to mixed eating.
- Cardiovascular risk is legitimately unclear. High saturated fat intake raises LDL in most men, though HDL and triglyceride patterns can improve.
- Social and family costs are substantial. Every meal becomes a negotiation.
- Nutrient deficiencies possible over time (vitamin C is theoretically covered by organ meats but most men aren't eating liver regularly).
- Effectiveness plateaus. Initial rapid loss often slows substantially.
- Research base is very thin — mostly anecdote and small case series.
- Colorectal cancer risk questions from processed meat and overall red meat intake at high volumes are real epidemiologically, though causation is complex.
Where fasting fails
- Effect size is smaller than the other two approaches.
- Meta-analyses of IF vs. simple caloric restriction generally show equivalent effects — IF isn't magical, just structured.3
- Hard to maintain during high-demand life periods (work travel, family events).
- Men with history of disordered eating should be cautious.
- Doesn't address the food-noise and appetite-signaling issues that drive most overweight.
- Prolonged fasting (72+ hours) has real safety concerns for men over 50 with cardiovascular risk factors.
- Most men eventually compensate during feeding windows and don't sustain the caloric deficit.
The "why not combine them" question
Many men end up running hybrid protocols — GLP-1 plus time-restricted eating plus high-protein-forward diet. This is reasonable and often the best pattern for body composition:
- GLP-1 handles the appetite and food-noise problem.
- Time-restricted eating (16:8 or similar) structures the day.
- Protein-forward eating with emphasis on animal protein preserves muscle.
- Resistance training 3x/week builds the physique.
- Adequate plant food covers fiber, polyphenols, and nutrient gaps.
This integrated approach takes what works from each philosophy without committing to the most extreme version. For most men over 40, this is substantially better than any pure approach.
The over-40 metabolic context
Men over 40 face specific metabolic realities that change the calculation:
- Testosterone is declining ~1% per year. This affects muscle mass, body composition, energy, libido.
- Resting metabolic rate is declining. Same calories that maintained weight at 30 now add fat at 45.
- Insulin sensitivity declines. Glucose handling worsens with age.
- Recovery from intense training slows. Aggressive deficits produce worse outcomes than at 25.
- Cardiovascular risk accumulates. Approaches that worsen lipid profile matter more after 40.
- Muscle loss (sarcopenia) becomes the critical concern. The goal isn't just losing fat; it's losing fat while preserving or gaining muscle.
Against this background, approaches that preserve muscle and address hormonal normalization are more valuable than approaches that maximize scale weight loss at the cost of lean mass.
The adherence reality
Most discussions of diet interventions ignore the central issue: whether people actually stick with them.
A useful reframe: the best diet is the one you'll actually follow for 10 years. The 20% weight loss that carnivore produces in the 20% of men who sustain it is less impactful at population level than the 10% weight loss that happens in 60% of men with a more flexible approach.
GLP-1s win this battle decisively. The drug carries the behavioral burden, so adherence at 1 year is ~85% and at 5 years remains much higher than any diet intervention.
The cardiometabolic outcomes comparison
For men with cardiovascular risk factors, the evidence strongly favors GLP-1s:
- GLP-1s: SELECT trial demonstrated 20% MACE reduction (semaglutide 2.4 mg).4
- Carnivore: No outcomes trials. Observational data on high-saturated-fat/high-red-meat diets shows mixed cardiovascular signals. LDL typically rises.
- Fasting: No dedicated outcomes trials. Meta-analyses suggest modest improvements in cardiovascular risk markers equivalent to caloric restriction.
For men with established cardiovascular disease or significant risk factors, GLP-1s have evidence-based benefit that the other two approaches lack.
Who each approach serves best
GLP-1s fit best for
- Men with BMI over 30, or 27+ with comorbidities.
- Men who've tried diet approaches multiple times and regained.
- Men with cardiovascular risk factors wanting evidence-based prevention.
- Men with type 2 diabetes or pre-diabetes.
- Men with demanding lives that don't accommodate rigid diet rules.
- Men who want to leverage 2026 pricing to make it affordable.
Carnivore fits best for
- Men with specific autoimmune or GI conditions that have responded to elimination approaches.
- Men who genuinely prefer simple binary rules.
- Men who can tolerate social and family friction for dietary reasons.
- Men who are willing to do regular lipid monitoring.
- Men who don't have established cardiovascular disease.
Fasting fits best for
- Men with moderate weight to lose (5–15% target).
- Men who want a free and flexible approach.
- Men with good insulin sensitivity and no metabolic dysfunction.
- Men who respond well to structure without strict food rules.
- Men who can manage social situations around feeding windows.
The combined recommendation for most men over 40
For the average 45-year-old man with 30+ lbs to lose, moderate cardiovascular risk, and a normal life (family, career, social obligations), the highest-probability successful approach is:
- Low-dose GLP-1 maintenance (semaglutide or tirzepatide). Handles appetite and food noise.
- Time-restricted eating (16:8 pattern). Structures the day without rigid rules.
- Protein-forward diet with adequate plant food. 1 g/lb goal weight protein, heavy on meat, eggs, fish, dairy; moderate on plants for fiber and micronutrients.
- Resistance training 3x/week. Preserves muscle while fat is dropping.
- Regular labs every 6 months. Track testosterone, lipids, glucose, inflammation.
This integrated approach takes what works from each philosophy without committing to the most extreme version of any. Effect size is comparable to the best outcomes from pure interventions, with substantially better adherence and safety profile.
The foundation that makes everything else work
GLP-1 therapy is the most evidence-backed component of an effective men's protocol for over-40 body composition. Start there, layer other interventions on top as they fit your life.
Check Synergy Rx Eligibility → Synergy Rx offers physician-led GLP-1 programs with real clinical oversight. Prefer results-focused programs? SHED. Want brand-name FDA-approved prescriptions? Sesame Care via licensed US physicians.The bottom line
GLP-1s, carnivore, and fasting are not equivalent interventions. The evidence gap is wide — GLP-1s have tens of thousands of patient-years of RCT data; carnivore and fasting have anecdote, observational data, and smaller trials.
For men over 40 with weight to lose and cardiovascular risk factors, GLP-1s produce the largest effect size with the highest adherence and the strongest safety data. The evidence-based answer is clear even when the cultural conversation isn't.
That doesn't mean carnivore and fasting have no place. Both work for specific men in specific situations. Both can be layered onto a GLP-1 protocol for hybrid approaches. Neither should be dismissed out of hand — but neither should be positioned as equivalent to the pharmacologically validated option.
If you're choosing one intervention to commit to as a man over 40: GLP-1 therapy, run well, with training and protein and reasonable nutrition, is the highest-probability winner. Layer fasting patterns onto it. Incorporate carnivore-adjacent principles (high-quality protein, plenty of animal foods, moderate plant intake) without the absolutism.
The dogmatic communities on each side want you to pick a lane. The evidence suggests a more flexible hybrid works best for most men — and that the drug component is the most impactful single piece.
References
- Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). NEJM, 2022.
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). NEJM, 2021.
- Patikorn C et al. Intermittent fasting and weight change: systematic review and meta-analysis. JAMA Network Open, 2021 (and subsequent meta-analyses).
- Lincoff AM et al. SELECT cardiovascular outcomes. NEJM, 2023.
- Portillo Canales S et al. Anti-obesity medications and testosterone normalization. ENDO 2025.
- Wilding JPH et al. STEP 1 trial extension weight regain data. Diabetes Obes Metab, 2022.